Header Logo

Connection

Mark Scharf to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Mark Scharf has written about Antibodies, Monoclonal, Humanized.
Mark Scharf
Connection Strength
0.694
Antibodies, Monoclonal, Humanized
  1. Blankenship K, Burns L, Scharf M. Vedolizumab-Induced Acne Fulminans: An Uncommon and Severe Adverse Effect. Cutis. 2022 09; 110(3):E19-E20.
    View in: PubMed
    Score: 0.694
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.